Literature DB >> 25990890

Comparative effectiveness of quality improvement interventions for pressure ulcer prevention in academic medical centers in the United States.

William V Padula1, Mary Beth F Makic, Manish K Mishra, Jonathan D Campbell, Kavita V Nair, Heidi L Wald, Robert J Valuck.   

Abstract

BACKGROUND: Prevention of pressure ulcers, one of the hospital-acquired conditions (HACs) targeted by the 2008 nonpayment policy of the Centers for Medicare & Medicaid Services (CMS), is a critical issue. This study was conducted to determine the comparative effectiveness of quality improvement (QI) interventions associated with reduced hospital-acquired pressure ulcer (HAPU) rates.
METHODS: In an quasi-experimental design, interrupted time series analyses were conducted to determine the correlation between HAPU incidence rates and adoption of QI interventions. Among University HealthSystem Consortium hospitals, 55 academic medical centers were surveyed from September 2007 through February 2012 for adoption patterns of QI interventions for pressure ulcer prevention, and hospital-level data for 5,208 pressure ulcer cases were analyzed. Between- and within-hospital reduction significance was tested with t-tests post-CMS policy intervention.
RESULTS: Fifty-three (96%) of the 55 hospitals used QI interventions for pressure ulcer prevention. The effect size analysis identified five effective interventions that each reduced pressure ulcer rates by greater than 1 case per 1,000 patient discharges per quarter: leadership initiatives, visual tools, pressure ulcer staging, skin care, and patient nutrition. The greatest reductions in rates occurred earlier in the adoption process (p<.05).
CONCLUSIONS: Five QI interventions had clinically meaningful associations with reduced stage III and IV HAPU incidence rates in 55 academic medical centers. These QI interventions can be used in support of an evidence-based prevention protocol for pressure ulcers. Hospitals can not only use these findings from this study as part of a QI bundle for preventing HAPUs.

Entities:  

Mesh:

Year:  2015        PMID: 25990890     DOI: 10.1016/s1553-7250(15)41034-7

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  6 in total

Review 1.  Measuring the quality of pressure ulcer prevention: A systematic mapping review of quality indicators.

Authors:  Jan Kottner; Elisabeth Hahnel; Andrea Lichterfeld-Kottner; Ulrike Blume-Peytavi; Andreas Büscher
Journal:  Int Wound J       Date:  2017-11-27       Impact factor: 3.315

2.  Using clinical data to predict high-cost performance coding issues associated with pressure ulcers: a multilevel cohort model.

Authors:  William V Padula; Robert D Gibbons; Peter J Pronovost; Donald Hedeker; Manish K Mishra; Mary Beth F Makic; John Fp Bridges; Heidi L Wald; Robert J Valuck; Adam J Ginensky; Anthony Ursitti; Laura Ruth Venable; Ziv Epstein; David O Meltzer
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

3.  Effectiveness and Value of Prophylactic 5-Layer Foam Sacral Dressings to Prevent Hospital-Acquired Pressure Injuries in Acute Care Hospitals: An Observational Cohort Study.

Authors:  William V Padula
Journal:  J Wound Ostomy Continence Nurs       Date:  2017 Sep/Oct       Impact factor: 1.741

4.  Quantitative iTRAQ LC-MS/MS reveals muscular proteome profiles of deep pressure ulcers.

Authors:  Zan Liu; Xu Cui; Yanke Hu; Pihong Zhang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

5.  Prevalence of Pressure Injuries Nationwide from 2009 to 2015: Results from the National Inpatient Sample Database in Korea.

Authors:  Gyeong Hoe Kim; Jin Yong Lee; Jayeun Kim; Hyun Joo Kim; Ji-Ung Park
Journal:  Int J Environ Res Public Health       Date:  2019-02-27       Impact factor: 3.390

6.  Investing in Skilled Specialists to Grow Hospital Infrastructure for Quality Improvement.

Authors:  William V Padula; Madhuram Nagarajan; Patricia M Davidson; Peter J Pronovost
Journal:  J Patient Saf       Date:  2021-01-01       Impact factor: 2.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.